Sex-dependent endocrine and cellular effects of the GnRH antagonist degarelix in rabbits and cell models. [PDF]
Zhao M +11 more
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Anesthetic Management for Pituitary Tumor Resection in a Patient With Acromegalic Cardiomyopathy: A Case Report. [PDF]
Yang S, Wang M.
europepmc +1 more source
Progression From Isolated Posterior Pituitary Dysfunction to Combined Anterior Hormone Deficiencies With Pituitary Stalk Enlargement in Suspected Lymphocytic Hypophysitis: A Case Report. [PDF]
Sasaki H, Yagi K, Kuga Y, Katahira H.
europepmc +1 more source
Revisiting Pituitary Incidentalomas: Insights from Prevalence Data and Consensus Recommendations. [PDF]
Hwang YA, Ku CR.
europepmc +1 more source
Development of Multiple Autoimmune and Endocrine Disorders Following COVID-19 Vaccination: A Case Report. [PDF]
Almutairi AM +4 more
europepmc +1 more source
Urinary Corticoid-to-Creatinine Ratio 8 Hours After Low-Dose Oral Dexamethasone for the Diagnosis of Cushing's Syndrome in Dogs. [PDF]
Soler Arias EA, Kooistra HS.
europepmc +1 more source
Autoimmune hypophysitis associated with rheumatoid arthritis: Histopathological insights from a rare biopsy-proven case. [PDF]
Javidialsaadi M +5 more
europepmc +1 more source

